Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Karen Soares

General Counsel at Clover Health Investments, Corp. /De (CLOV)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $337K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 15SEC CLOVClover Health Investments, Corp. /De Sell Plan 6,8461,607,371 held (−0%) $4.78 $33K -6.3%
Jul 20SEC CLOVClover Health Investments, Corp. /De Sell Plan 51,7001,505,522 held (−3%) $4.51 $233K -0.7%
Jul 16SEC CLOVClover Health Investments, Corp. /De Sell Plan 10,5191,557,222 held (−1%) $4.67 $49K -4.1%
Jun 16SEC CLOVClover Health Investments, Corp. /De Sell Plan 4,6811,567,741 held (−0%) $4.61 $22K -2.8%
  • Sell

    General Counsel Karen Soares sold $33K of CLOV at $4.78 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Karen Soares sold $233K of CLOV at $4.51 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Karen Soares sold $49K of CLOV at $4.67 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Karen Soares sold $22K of CLOV at $4.61 — pre-scheduled 10b5-1 plan sale.